Log in

2256 Abbisko Cayman Limited HKEX · China

Abbisko Cayman (2256) news

Abbisko Cayman Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2256, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Abbisko Cayman news

We have not published a story on Abbisko Cayman yet. When there is news, it will appear here.

Questions about Abbisko Cayman

What is the ticker symbol of Abbisko Cayman?

Abbisko Cayman Limited trades under the ticker 2256 on HKEX.

Where is Abbisko Cayman listed?

Abbisko Cayman Limited is listed on HKEX. Our directory also records these other listings: LSX:A3C4Y0.

Which country or territory is Abbisko Cayman listed under?

Our directory records Abbisko Cayman Limited under China.

What does Abbisko Cayman do?

Our directory classifies Abbisko Cayman Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Abbisko Cayman?

The ISIN recorded for Abbisko Cayman Limited is KYG0028A1085.

Does aibio.space cover Abbisko Cayman?

aibio.space lists Abbisko Cayman Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Abbisko Cayman?

Companies in our directory listed in the same country and business area as Abbisko Cayman: CSPC Hunan Jingfeng Pharmaceutical Co, Hinova Pharmaceuticals, Hainan Haiyao Co., North China Pharmaceutical Company, Changzhou Qianhong Bio-Pharma Co., Apeloa Pharmaceutical Co..

Investor discussion: Abbisko Cayman

Members talk about Abbisko Cayman (2256). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Abbisko Cayman, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. Source

  2. Financings

    Share or debt issue: PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. Source

  3. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - SUBSCRIPTIONS OF WEALTH MANAGEMENT PRODUCTS. Source

Press releases

Headlines of Abbisko Cayman's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS' LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA GRANTED ORPHAN DESIGNATION BY EMA

  2. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES POSITIVE PRELIMINARY PHASE II RESULTS WITH LAVENGRATINIB (ABSK061) FOR THE TREATMENT OF ACHONDROPLASIA

  3. HKEXnews

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 17, 2026

  4. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS COMPLETES FIRST PATIENT DOSING IN PHASE I CLINICAL TRIAL OF NOVEL PAN-KRAS INHIBITOR ABSK211

  5. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  6. HKEXnews

    PROPOSED CHANGE OF COMPANY NAME AND NOTICE OF EXTRAORDINARY GENERAL MEETING

  7. HKEXnews

    PROPOSED CHANGE OF COMPANY NAME

  8. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES IND CLEARANCE FROM THE NMPA FOR ORAL SMALL MOLECULE PAN-KRAS INHIBITOR ABSK211

  10. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS ANNOUNCES IND CLEARANCE FROM THE FDA FOR ORAL SMALL MOLECULE PAN-KRAS INHIBITOR ABSK211

  11. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS AND ASTRAZENECA ENTER A STRATEGIC COLLABORATION TO CONDUCT THE CLINICAL TRIAL OF LUMIPODLIN (ABSK043), A FIRST-IN-CLASS ORAL PD-L1 INHIBITOR, IN COMBINATION WITH TAGRISSO FOR NSCLC

  12. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS REPORTS PHASE II DATA OF ABSK061 IN COMBINATION WITH ABSK043 IN FGFR2-POSITIVE ADVANCED GC/GEJC PRESENTED AT 2026 ASCO

  13. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS DEEPENS R&D COLLABORATION WITH LILLY

  14. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ABBISKO THERAPEUTICS PRESENTS A NOVEL JOINT MODELING FRAMEWORK FOR ABSK-011 (IRPAGRATINIB) IN HCC PATIENTS AT THE PAGE MEETING

  15. HKEXnews

    ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  16. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 20, 2026 AND AMENDMENTS TO THE ARTICLES

  17. HKEXnews

    COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE

  18. HKEXnews

    Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications

  19. HKEXnews

    Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications

  20. HKEXnews

    NOTICE OF THE ANNUAL GENERAL MEETING

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2256 on TradingView.

Listing details

Abbisko Cayman Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2256, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Abbisko Cayman Limited
Ticker
2256
Listing
HKEX
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
KYG0028A1085
Other listed symbols
LSX:A3C4Y0
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.